US FDA Tags Theranos Sample Tubes As Uncleared Devices
This article was originally published in Clinica
Executive Summary
The US FDA has stated that the Nanotainer blood specimen collection tubes made by embattled laboratory firm Theranos were being sold without proper 510(k) clearance and also cited the firm for a range of Quality System Regulation deficiencies in two FDA Form-483s posted online Oct. 27.
You may also be interested in...
Theranos' Holmes, Balwani Slammed By SEC For 'Massive Fraud'
In another blow from the US government, securities regulators have severely penalized Theranos and its cofounder, Elizabeth Holmes, for allegedly lying to investors to raise funds.
Beauty Packaging Producers: July Marks Registration Deadline With PRO In Three States
Companies considered producers of single-use packaging in Oregon, Colorado and California must register with Circular Action Alliance, the leading (and currently only) producer responsibility organization, by 1 July 2024 under new state recycling laws.
Metsera Launches As New Obesity Contender Flush With $290m
Clive Meanwell, former CEO of The Medicines Company, will helm the new company, backed by ARCH and other investors. He talked to Scrip about the new venture.